References
- Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71–6.
- Schulte C, Dignass AU, Mann K, Goebell H. Reduced bone mineral density and unbalanced bone metabolism in patients with inflammatory bowel disease. Inflam Bowel Dis 1998;4: 268–75.
- Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228–33.
- Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn’s disease but not in patients with ulcerative colitis: a population-based study. Gut 1997;40:313–9.
- Dinca M, Fries W, Luisetto G, Peccolo F, Bottega F, Leone L, et al. Evolution of osteopenia in inflammatory bowel disease. Am J Gastroenterol 1999;94:1292–7.
- Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel disease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250–6.
- Rigaud D, Angel LA, Cerf M, Carduner MJ, Melchior JC, Sautier C, et al. Mechanisms of decreased food intake during weight loss in adult Crohn’s disease patients without obvious malabsorption. Am J Clin Nutr 1994;60:775–81.
- Vogelsang H, Klamert M, Resch H, Ferenci P. Dietary vitamin D intake in patients with Crohn’s disease. Wien Klin Wochen- schr 1995;107:578–81.
- Silvennoinen J, Lamberg-Allardt C, Karkkainen M, Niemela S, Lehtola J. Dietary calcium intake and its relation to bone mineral density in patients with inflammatory bowel disease. J Intern Med 1996;240:285–92.
- Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn’s disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031–9.
- Haugeberg G, Myklebust G, Dovland H, Mikkelsen B, Gran JT. No permanent reduction in bone mineral density during treatment of polymyalgia rheumatica and temporal arteritis using low dose corticosteroids. Scand J Rheumatol 2000;28:1–7.
- Kanis JA, Melton LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994;9:1137–41.
- Vestergaard P, Krogh K, Rejnmark L, Laurberg S, Mosekilde L. Fracture risk is increased in Crohn’s disease, but not in ulcerative colitis. Gut 2000;46:176–81.
- Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Intern Med 1996;239:131–7.
- Bernstein CN, Seeger LL, Anton PA, Artinian L, Geffrey S, Goodman W, et al. A randomized, placebo-controlled trial of calcium supplementation for decreased bone density in corticosteroid using patients with inflammatory bowel disease: a pilot study. Aliment Pharmacol Ther 1996;10:777–86.
- Vogelsang H, Ferenci P, Resch H, Kiss A, Gangl A. Prevention of bone mineral loss in patients with Crohn’s disease by longterm oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609–14.
- Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993;23: 95–104.
- MacDonald BR, Gowen M. Cytokines and bone. Br J Rheumatol 1992;31:149–55.
- Bartram SA, Thompson NP, Peaston R, Francis RM. Osteoporosis and bone metabolism in patients with Crohn’s disease. Arthritis Rheum 1999;42 Suppl 9:358.
- Klaus J, Bruckel J, Steinkamp M, Reinshagen M, Adler G, Rieber A, et al. High prevalence of vertebral fractures in patients with Crohn‘s disease evaluated by quantitative morphometry. Osteoporos Int 2000;11 Suppl 2:161.